Immunique
About us
R&D
Careers
EN
KR
About us
Beyond Treatment
Toward a Better Life
CEO Message
Overview
Our Philosophy
People & Network
R&D
Redefining Immunity
Through Data
Platform
Regenerative Medicine
Pipeline
Careers
Careers
Careers
Home
About us
Redefining Healthy Longevity
Through Precision Immune Resilience
CEO Message
Overview
Our Philosophy
People & Network
Overview
Company
Redefining Recovery Beyond Treatment
History
Our Journey Toward a Healthier Future
2021
Apr.
IMMUNIQUE Inc. established
Nov.
Certified as a Venture Enterprise
2022
Feb.
Established the R&D Center for Cellular Immunotherapy
Apr.
Certified as a Corporate-Affiliated Research Institute
Nov.
Patent application filed: Enhanced regulatory T cells and method of manufacturing
thereof
2023
Mar.
Signed an MOU for joint R&D with the Hanyang University Institute for
Rheumatology Research
Apr.
Selected for a national R&D project under the Korean Fund for Regenerative
Medicine
Nov.
Signed an MOU for joint R&D with Kine Sciences
2024
Jun.
Winner of the 2024 Korea Leading Company Award — Bio Category
Sep.
Appointment of SO MEE KWON as CEO
2025
Jun.
Selected as a corporate partner in Ajou University Hospital’s Korea Research-Driven
Hospitals
Sep.
Signed an MOU for joint R&D with Ewha Womans University Mokdong Hospital
Dec.
Signed an MOU for educational cooperation with CHA University Graduate School
of Clinical Pharmacy
Address
Address
Directions
21, Daewangpangyo-ro 644-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13494, Korea
031-620-4200
031-620-4299